Flumexadol

CHEMBL578767 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
231.2 g/mol
LogP
2.0
Phase
4

A sedative medication that works on the central nervous system to produce calming and sleep-inducing effects. It has been investigated for its potential use in managing anxiety and sleep disorders.

Berat Molekul

231,2100 g/mol

LogP

2,00

TPSA

21,30 Ų

Lipinski RO5

Lulus

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

FC(F)(F)c1cccc(C2CNCCO2)c1

InChI

InChI=1S/C11H12F3NO/c12-11(13,14)9-3-1-2-8(6-9)10-7-15-4-5-16-10/h1-3,6,10,15H,4-5,7H2

Molecular Formula

C11H12F3NO

HBD / HBA

1 / 5

Ikatan yang Dapat Dirotasi

1

Atom Berat

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

A sedative medication that works on the central nervous system to produce calming and sleep-inducing effects. It has been investigated for its potential use in managing anxiety and sleep disorders.

Yes, Flumexadol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL578767. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 65774. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.